Israel Active

Israel’s Techsomed (see previously) has received US FDA approval for its BioTraceIO360 software platform to be used to burn or freeze kidney tumors. The device was previously approved only for destroying liver tumors.

Israel’s PatenSee (see previously) has received US FDA Breakthrough Device Designation for its non-contact vascular access (VA) management technology designed for patients undergoing hemodialysis. Its imaging & AI warns of fistula deterioration.

Following 4 major US trials, the ES device from Israel’s Pulsenmore (see previously) has received US-FDA approval. It allows pregnant US women to carry out ultrasound fetal monitoring at home and will expand access to prenatal care in areas facing physician shortages.

Scientists at the Hebrew University of Jerusalem have developed mass spectrometry imaging (MSI), combined with an automated computational tool, to quickly analyze how topical medications, from antifungal creams to anti-aging serums, navigate and absorb the layers of the skin.

Scientists at Israel’s Technion Institute have developed biomimetic hydrogel bio-adhesives that can seal wounds quickly and effectively even under extreme conditions and environments. The scientists were inspired by how mollusks / molluscs adhere to wet surfaces.

The UK’s National Health Service in Liverpool, London and Newcastle is using the BV test from Israel’s MeMed to decide whether a patient is suffering from a bacterial or viral infection. It speeds up treatment of sepsis, meningitis, etc., and prevents unnecessary use of antibiotics.

Israel's national emergency volunteer organization, United Hatzalah, proudly announced the dedication of 80 new emergency motorcycles ("Ambu-cycles") to celebrate the 80th birthday of philanthropist and friend Dr. Miriam Adelson.

Nefesh B’Nefesh, in cooperation with The Jewish Agency for Israel, hosted the first-ever MedEx events in Australia, for over 100 Jewish doctors in Sydney and Melbourne. It is part of the International Medical Aliyah Program (IMAP), streamlining the process for doctors making Aliyah.

The UK Embassy in Israel has launched the 2nd cohort of the Dangoor Health-Tech Academy, a joint initiative by the UK-Israel Tech Hub and the Dangoor Foundation. The 8-week program connects Israeli health-tech start-ups with the UK healthcare ecosystem, focusing on mental-health innovation.

Researchers from University of Haifa’s Sagol Department of Neurobiology have combined genetics and AI to detect suicidal tendencies in bipolar patients with near-perfect precision, offering a new hope for early intervention. They identified distinctive molecular signatures in high-risk patients.